• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Corrigendum to "AGBL2 promotes cancer cell growth through IRGM-regulated autophagy and enhanced Aurora A activity in hepatocellular carcinoma" [Canc. Lett. 414 (2018) 71-80].

作者信息

Wang Li-Li, Jin Xiao-Han, Cai Mu-Yan, Li Hai-Gang, Chen Jie-Wei, Wang Feng-Wei, Wang Chen-Yuan, Hu Wei-Wei, Liu Fang, Xie Dan

机构信息

State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-Sen University Cancer Center, Guangzhou, Guangdong, China; Department of Pathology, The First People's Hospital of Foshan, Foshan, Guangdong, China.

State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-Sen University Cancer Center, Guangzhou, Guangdong, China.

出版信息

Cancer Lett. 2022 Jul 28;539:215700. doi: 10.1016/j.canlet.2022.215700. Epub 2022 May 4.

DOI:10.1016/j.canlet.2022.215700
PMID:35525812
Abstract
摘要

相似文献

1
Corrigendum to "AGBL2 promotes cancer cell growth through IRGM-regulated autophagy and enhanced Aurora A activity in hepatocellular carcinoma" [Canc. Lett. 414 (2018) 71-80].《AGBL2通过IRGM调节的自噬和增强的极光激酶A活性促进肝癌细胞生长》[《癌症通讯》414(2018)71 - 80]的勘误
Cancer Lett. 2022 Jul 28;539:215700. doi: 10.1016/j.canlet.2022.215700. Epub 2022 May 4.
2
AGBL2 promotes cancer cell growth through IRGM-regulated autophagy and enhanced Aurora A activity in hepatocellular carcinoma.AGBL2 通过 IRGM 调控的自噬和增强肝癌细胞中的 Aurora A 活性促进癌细胞生长。
Cancer Lett. 2018 Feb 1;414:71-80. doi: 10.1016/j.canlet.2017.11.003. Epub 2017 Nov 8.
3
Corrigendum to "Circadian clock gene NPAS2 promotes reprogramming of glucose metabolism in hepatocellular carcinoma cells" [Canc. Lett. 469 (2020) 498-509].《昼夜节律钟基因NPAS2促进肝癌细胞葡萄糖代谢重编程》的勘误[《癌症通讯》469 (2020) 498 - 509]
Cancer Lett. 2021 Nov 28;521:322-323. doi: 10.1016/j.canlet.2021.09.006. Epub 2021 Sep 11.
4
Corrigendum to "NRF2/SHH signaling cascade promotes tumor-initiating cell lineage and drug resistance in hepatocellular carcinoma" [Canc. Lett. 476 (2020) 48-56].《NRF2/SHH信号级联促进肝细胞癌肿瘤起始细胞谱系及耐药性》[《癌症快报》476卷（2020年）第48 - 56页]的勘误
Cancer Lett. 2021 Feb 28;499:2. doi: 10.1016/j.canlet.2020.06.007. Epub 2020 Jun 17.
5
Corrigendum to "MicroRNA-21 suppresses PTEN and hSulf-1 expression and promotes hepatocellular carcinoma progression through AKT/ERK pathways" [Canc. Lett. 337 (2013) 226-236].《“MicroRNA-21通过AKT/ERK途径抑制PTEN和hSulf-1表达并促进肝细胞癌进展”的勘误》[《癌症快报》337 (2013) 226 - 236]
Cancer Lett. 2020 Mar 31;473:198-199. doi: 10.1016/j.canlet.2019.12.034. Epub 2020 Jan 8.
6
Corrigendum to "Long non-coding RNA Unigene 56159 promotes epithelial-mesenchymal transition by acting as a ceRNA of miR-140-5p in hepatocellular carcinoma cells" [Canc. Lett. 382 (2016) 166-175].《“长链非编码RNA Unigene 56159通过作为肝细胞癌细胞中miR-140-5p的ceRNA促进上皮-间质转化”的勘误》[《癌症快报》382 (2016) 166 - 175]
Cancer Lett. 2020 Mar 1;472:181-182. doi: 10.1016/j.canlet.2019.12.021. Epub 2019 Dec 24.
7
Corrigendum to "LncRNA n335586/miR-924/CKMT1A axis contributes to cell migration and invasion in hepatocellular carcinoma cells" [Canc. Lett. 429 (2018) 89-99].《“LncRNA n335586/miR-924/CKMT1A轴促进肝癌细胞的迁移和侵袭”的勘误》[《癌症快报》429 (2018) 89 - 99]
Cancer Lett. 2020 Dec 1;494:84-87. doi: 10.1016/j.canlet.2020.07.018. Epub 2020 Sep 7.
8
Corrigendum to "cPLA2α activates PI3K/AKT and inhibits Smad2/3 during epithelial-mesenchymal transition of hepatocellular carcinoma cells" [Canc. Lett. 403 (2017) 260-270].《“cPLA2α在肝癌细胞上皮-间质转化过程中激活PI3K/AKT并抑制Smad2/3”的勘误》[《癌症快报》403卷（2017年）260 - 270页]
Cancer Lett. 2021 Feb 1;498:240-241. doi: 10.1016/j.canlet.2020.11.009. Epub 2020 Nov 19.
9
High expression of AGBL2 is a novel prognostic factor of adverse outcome in patients with ovarian carcinoma.AGBL2的高表达是卵巢癌患者不良预后的一个新的预后因素。
Oncol Lett. 2019 Nov;18(5):4900-4906. doi: 10.3892/ol.2019.10829. Epub 2019 Sep 9.
10
Corrigendum to "Targeting autophagy in cancer stem cells as an anticancer therapy" [Canc. Lett. 393 (2017) 33-39].
Cancer Lett. 2018 Mar 1;416:149. doi: 10.1016/j.canlet.2017.12.027. Epub 2018 Jan 4.